| HS Code | 624295 |
| Generic Name | Terbinafine Hydrochloride |
| Chemical Formula | C21H26ClN |
| Molecular Weight | 327.89 g/mol |
| Drug Class | Antifungal (Allylamine) |
| Appearance | White to off-white crystalline powder |
| Solubility | Slightly soluble in water, freely soluble in methanol and ethanol |
| Mechanism Of Action | Inhibits squalene epoxidase, leading to ergosterol deficiency in fungal cell membranes |
| Route Of Administration | Oral, topical |
| Atc Code | D01BA02 |
| Cas Number | 78628-80-5 |
| Indications | Treatment of fungal infections such as athlete's foot, ringworm, and nail fungus |
| Storage Conditions | Store at 20°C to 25°C (68°F to 77°F) |
As an accredited Terbinafine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Terbinafine Hydrochloride is packaged in a sealed, amber glass bottle containing 100 grams, labeled with batch number, expiry date, and hazard warnings. |
| Shipping | Terbinafine Hydrochloride is shipped in tightly sealed containers to protect from moisture and light. It should be stored and transported at controlled room temperature, avoiding excessive heat and humidity. Shipments comply with applicable regulations for pharmaceuticals, including hazard labeling and documentation, ensuring safe handling and delivery to the destination. |
| Storage | Terbinafine Hydrochloride should be stored in a tightly closed container, protected from light and moisture. Keep it at controlled room temperature, ideally between 20°C and 25°C (68°F to 77°F). Avoid exposure to heat or freezing temperatures. Store away from incompatible substances such as strong oxidizers, and always keep out of reach of children and unauthorized personnel. |
Competitive Terbinafine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Each batch of Terbinafine Hydrochloride reflects years of hands-on chemical manufacturing experience. Developing this product began with recognizing the clinical need for targeted antifungal agents that combine potency, purity, and process stability. Looking back at initial pilot runs, attention to the stability parameters and crystallinity formed the basis for a consistently robust process. Our team spends time at the reactor, measuring reaction temperature and pH, checking flow rates, and overseeing filtration—not just ticking boxes in a laboratory but ensuring that what leaves our site meets rigorous global pharmacopoeia standards.
Terbinafine Hydrochloride appears as a white to off-white crystalline powder after purification, with an assay typically exceeding 99%. Moisture control during processing impacts solubility in final dosage forms. Granulation relies on precise process timing and thorough drying to achieve the right density, which downstream formulators appreciate for ease of blending. We’ve had to refine solvent systems and isolation steps over time, driven by the lessons of each production run.
Our standard model bears an assay of not less than 99.0%, with controlled impurity thresholds well below international pharmacopeial limits. Loss on drying sits below 0.5%, so product managers at formulation plants notice no caking or unexpected clumping in storage. Particle size distribution matches the needs of both oral tablet and topical cream manufacturers. As our chemists fine-tune milling, they listen to customer feedback on tablet disintegration or the spreadability in creams. Customers may request customized grades for niche delivery forms, but at its core, uniform crystalline Terbinafine Hydrochloride remains the workhorse.
Impurities can sometimes spark concern during regulatory inspections. Having walked factory floors during campaigns, our quality team traces every lot and carries out impurity profile mapping with advanced chromatographic methods. Residual solvents, heavy metals, and specific related compounds—such as N-desmethyl derivatives or any process-related intermediates—are all kept under control. These efforts matter to both finished drug manufacturers and their end users, since product recalls stem from overlooked trace contaminants.
Producing Terbinafine Hydrochloride requires deep understanding of naphthalene ring systems and the challenges of maintaining chirality. Despite advancements in technology, the hands-on skills of operators—how they adjust stirring speeds, when to quench reactions, the timing of each filtration—continue to shape outcomes. During scale-up periods, unexpected foaming or color changes give early signals about process deviations. Meticulous tracking logs help identify variations that most automated systems ignore.
Decision making often goes beyond following SOPs. Staff deal with real-world constraints: fluctuations in voltage, changes in feedstock quality, or seasonal humidity shifts. Each adjustment in process variables leaves a mark on the final Terbinafine Hydrochloride. Some of our finest improvements arose from floor discussions with production veterans who caught issues before QC labs flagged them.
Terbinafine Hydrochloride set a new standard in antifungal therapy by directly targeting fungal squalene epoxidase, disrupting ergosterol synthesis in dermatophytes and yeasts. Pharmacists and physicians rely on this selectivity to manage tinea, ringworm, and athlete’s foot. With rising antifungal resistance, the demand for reproducibly pure Terbinafine Hydrochloride products has climbed. We focus on supplying API with minimal by-product content so drug manufacturers can meet label claims without excess overages.
Preparation for different regions requires adapting batch sizes, packaging formats, and stability testing to local conditions. For humid areas, we work closely with packaging partners to offer extra-desiccated pouches or tamper-proof drums. Supply chain disruptions—whether due to logistics bottlenecks or raw material shortages—have provided teachable moments. We maintain buffer stocks of critical intermediates and refine lean schedules so hospitals and pharmacies never face product shortages.
Meeting compliance is a foundation, not an endpoint. Customers expect proactive communication, not just certificates of analysis. We regularly invite downstream partners to witness manufacturing audits and discuss how our in-process controls align with their final product requirements. As active participants in the Drug Master File (DMF) process, our documentation withstands inspection by regulators from the US FDA, EMA, and domestic authorities.
Recalls in the pharmaceutical space often result from oversight on trace contaminants or mix-ups in labeling. Drawing on our own audit experiences, we maintain a recall readiness protocol: every drum can be traced to a shift, a reactor, and a logbook entry. This approach builds confidence with partners aiming for global launches.
Terbinafine Hydrochloride stands apart from imidazole group products like clotrimazole and ketoconazole. From a chemical viewpoint, terbinafine’s allylamine structure gives higher fungicidal activity at lower dosages. During formulation troubleshooting sessions, we’ve seen that terbinafine’s unique solubility profile allows for higher drug loading in creams and oral forms with less risk of precipitation. Manufacturing teams choosing between terbinafine and triazoles notice shelf life advantages for certain dispersible formats, due to reduced sensitivity to hydrolysis.
Cost per kilogram may not reflect the total advantage. Downstream, formulators can use lower amounts of terbinafine due to its mode of action. Batch homogeneity and ease of wet granulation also rank higher than with azole APIs. We’ve noticed fewer process interruptions and less wear on blending equipment because the API blends more predictably with excipients. This translates into cost savings for large-scale drug producers.
On an industrial scale, the waste treatment profile for Terbinafine Hydrochloride also differs. Our waste management teams observe that the typical by-products and solvent residues require less complex neutralization than those from azole production lines. This matters for environmental permits, and provides an edge in markets where green chemistry audits play a growing role.
The last few years have thrown all manufacturers into supply chain unknowns. Terbinafine Hydrochloride production depends on precursors sourced internationally. Disruptions upstream in aromatic amines or naphthalene intermediates have a ripple effect. By diversifying supplier bases and investing in local feedstock initiatives, we keep the line running without large cost surges. Conversations with key suppliers take place weekly, and we track container movement and customs clearance closely. Our ERP system flags any anomaly for quick response.
Customers sometimes ask why pricing fluctuates even when demand seems steady. Price reflects not just market conditions but investments in raw material security. Storage and safety stock carry real costs, as does investment in hazard management and backup energy systems. Having lived through multiple global raw material crunches, we know that short-term savings on input costs often backfire if supply reliability drops.
Managing solvent emissions and minimizing energy use are not just regulatory requirements—they’re simply the right thing to do. Upgraded scrubber units capture over 98% of vented solvents. Steam recovery loops and improved insulation on reactors save thousands of cubic meters of fuel each year. Effluent treatment plants have seen incremental upgrades driven by both compliance and our own experiences with local communities.
As a manufacturer, new guidelines push us toward greener chemistries. Early pilot runs experimented with alternative solvents that promised lower toxicity but failed during scale-up due to unanticipated side reactions or product quality losses. Progress comes through gradual process improvements—finding safer reagents, reducing reaction steps, and installing more accurate dosing controls. Our staff undergoes regular training, not because regulations require it, but because accidental releases and near-misses stick in the memory and drive real change.
Pharmaceutical development teams depend on steady Terbinafine Hydrochloride quality, particularly during registration and scale-up of new drug products. We field specific inquiries related to polymorphic form, particle size modification, or potential for micronization. Direct conversations between our technical team and customer formulators solve many small but crucial issues—such as moisture pick-up during open handling or changes in slurry viscosity affecting capsule filling.
Maintaining a responsive feedback loop has reduced API wastage and rework in multiple client projects. As some customers shift from generic registration to innovative drug delivery formats, we offer tailored tech support, sometimes sending technical staff to client sites for troubleshooting. Chemists and engineers—many with more than a decade on the line—recognize repeat issues before they reach critical points.
Global demand for Terbinafine Hydrochloride saw a sharp rise with expanding generic access programs in regions struggling with skin infections. Yet seasonal shifts and national formulary changes influence order patterns. Data from the past five years points to cycles, so we build excess capacity during expected high-consumption months. Forecasting tools help, but nothing beats direct customer calls and real-world shipment tracking. Customers appreciate candor about lead times and available inventory, especially during pandemic-induced logistics crunches.
Changing regulatory environments in some markets now require extra analytical data—stability studies, elemental impurity testing, or genotoxic impurity screens. We invested in upgraded HPLC-MS equipment and retrained teams to extract, confirm, and trend these data points with every lot. New requests for environmental fate and biodegradable properties highlight shifting customer priorities.
Every campaign brings learning opportunities. Scale-up batches that once suffered marginal yield losses now hit tighter targets due to process control improvements. Production meetings focus on practical bottlenecks—agitation efficiency, clean-in-place validation, effluent color changes. Technical staff attend industry forums and bring back insights to adapt processes, avoiding both regulatory pitfalls and batch inconsistency.
Long-term relationships with both customers and suppliers create a cycle of trust. Feedback that began as critical—troubleshooting a capping defect linked to particle size—eventually led to a process tweak and improved product performance across the board.
Consistency isn’t a buzzword here—it forms the basis for success at both our facility and our customers’ plants. We’ve invested in redundant systems to avoid downtime. GMP and ISO standards guide our checks, but accountability comes directly from our workforce who track every lot journey from raw ingredient to finished drum. Years in the industry have taught us to never take short-cuts with documentation, sampling, or machine maintenance.
We stand ready to support customers facing urgent or complex projects. Whether the need is for a fresh certificate of analysis on a weekend, a special-grade shipment to meet expedited approval, or technical troubleshooting during validation, our team takes responsibility. In a changing global landscape, those personal connections and learned lessons allow us to deliver Terbinafine Hydrochloride that meets real-world demands, batch after batch.